PillRx only · Solution · Oral
Brivaracetam
Brands: Briviact · Brivaracetam
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers6 labelers
Packages6
DEA / ScheduleCV
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.180
Latest avg · Jun 17, 2026
-75%
Since Dec 17, 2025
6
Active US suppliers
33%
Top-2 supplier share*
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Novadoz Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
| Zhejiang Poly Pharm. Co., Ltd. | unknown | 1 | SUPPLYING |
| PAI Holdings, LLC dba PAI Pharma | unknown | 1 | SUPPLYING |
| UCB, Inc. | unknown | 1 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 1 | SUPPLYING |
| Ascend Laboratories, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.